Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza vaccine immune response in multiple sclerosis patients treated with teriflunomide
2011-001160-21Phase 2Completed
- Sponsor
- Sanofi
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of teriflunomide in multiple sclerosis (MS) and influenza (2 arms), sponsored by Sanofi. Primary endpoint: Seroprotection rate. Started May 2011; status: completed.
02
Drugs
teriflunomide
03
Conditions
multiple sclerosis (MS)influenza
Beyond the preview
Go deeper on 2011-001160-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001160-21.